Envista Holdings Corp (NVST) insider trading

By person

16 insiders · 0 transactions

12.4×

Paul Keel holds 12.4 times base salary in stock. $13.67M of shares against $1.10M in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Keel last reported holding, valued at $27.50, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Paul A Keel

Chairman and CEO

—

497,107

0.3095%

$13.67M

+42.6%

Eric D. Hammes

Chief Financial Officer

—

99,913

0.0622%

$2.75M

+12.6%

R Scott Huennekens

Director

—

82,105

0.0511%

$2.26M

+48.9%

Mark E Nance

General Counsel

—

81,252

0.0506%

$2.23M

+41.4%

Barbara B. Hulit

Director

—

79,820

0.0497%

$2.20M

+15.1%

Stefan Nilsson

President, Nobel Biocare

—

61,560

0.0383%

$1.69M

+35.4%

Wendy Carruthers

Director

—

59,940

0.0373%

$1.65M

+49.3%

Christine A Tsingos

Director

—

59,930

0.0373%

$1.65M

+49.3%

Faez C Kaabi

Chief Accounting Officer

—

58,552

0.0365%

$1.61M

+31.2%

Daniel Raskas

Director

—

54,010

0.0336%

$1.49M

+57.8%

Kieran Gallahue

Director

—

54,010

0.0336%

$1.49M

+57.8%

Vivek Jain

Director

—

52,945

0.0330%

$1.46M

+59.6%

Veronica Acurio

President, Orthodontics

—

48,806

0.0304%

$1.34M

+7.4%

Robert Befidi

President, Diagnostics

—

45,785

0.0285%

$1.26M

+15.1%

Mischa Reis

SVP, Strategy & Bus. Dev.

—

27,321

0.0170%

$751.33K

−36.0%

James Andrew Pierce

Director

—

18,485

0.0115%

$508.34K

—

Envista Holdings Corp

What the insiders did No buying or selling

By person